{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:31:46Z","timestamp":1792272706957,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.radonc.2018.02.028","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:55:46Z","timestamp":1520988946000},"page":"253-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer"],"prefix":"10.1016","volume":"127","author":[{"given":"Ronan L.","family":"McDermott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cormac","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"O'Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayle J.","family":"Hacking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.02.028_b0005","unstructured":"Cancer in Ireland 1994\u20132011: Annual report of the National Cancer Registry; 2014."},{"key":"10.1016\/j.radonc.2018.02.028_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2018.02.028_b0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1200\/JCO.2004.06.123","article-title":"Hypofractionated palliative radiotherapy (17\u202fGy per two fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial","volume":"22","author":"Sundstr\u00f8m","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0169-5002(95)00487-4","article-title":"Palliative radiation for stage 3 non-small cell lung cancer \u2013 a prospective study of two moderately high dose regimens","volume":"13","author":"Abratt","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/bjc.1991.62","article-title":"Inoperable non-small cell lung cancer (NSCLC): a Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions","volume":"63","author":"Medical Research Council Lung Cancer Working Party","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0030","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.1992.196","article-title":"A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer (NSCLC) and poor performance status","volume":"65","author":"Medical Research Council Lung Cancer Working Party","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0936-6555(96)80041-0","article-title":"Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status","volume":"8","author":"Macbeth","year":"1996","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.02.028_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0936-6555(05)80447-9","article-title":"Immediate side effects of large fraction radiotherapy","volume":"9","author":"Devereux","year":"1997","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.02.028_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clon.2004.09.008","article-title":"Symptom control and quality of life in People with Lung Cancer: a randomised trial of two palliative radiotherapy fractionation schedules","volume":"17","author":"Erridge","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2018.02.028_b0050","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1200\/JCO.2005.01.685","article-title":"Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non\u2013small-cell lung cancer","volume":"23","author":"Kramer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0055","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.bjc.6602477","article-title":"A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC)","volume":"92","author":"Senkus-Konefka","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0060","doi-asserted-by":"crossref","unstructured":"Stevens R, Macbeth F, Toy E, Coles B, Lester JF. Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer. Cochrane Database Syst Rev 2015;1:CD002143.","DOI":"10.1002\/14651858.CD002143.pub3"},{"key":"10.1016\/j.radonc.2018.02.028_b0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00066-013-0507-y","article-title":"Survival and prognostic factors after moderately hypofractionated palliative thoracic radiotherapy for non-small cell lung cancer","volume":"190","author":"van Oorschot","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2018.02.028_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2017.02.011","article-title":"Positron emission tomography and computed tomographic imaging (PET\/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: a systematic review and meta-analysis","volume":"123","author":"Hallqvist","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radonc.2016.09.002","article-title":"Multiple training interventions significantly improve reproducibility of PET\/CT-based lung cancer radiotherapy target volume delineation using an IAEA protocol","volume":"121","author":"Konert","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0360-3016(99)00095-4","article-title":"Dose escalation of CHART in non-small cell lung cancer: is three-dimensional conformal radiation therapy really necessary?","volume":"45","author":"McGibney","year":"1999","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1016\/j.radonc.2018.02.028_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2005.06.022","article-title":"EORTC Quality of Life Group. The development of the EORTC QLQ-C15 PAL: a shortened questionnaire for cancer patients in palliative care","volume":"42","author":"Groenvold","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organisation for Research and Treatment of Cancer QLQ C-30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Canc Inst"},{"key":"10.1016\/j.radonc.2018.02.028_b0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life","volume":"30A","author":"Bergmann","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.02.028_b0100","unstructured":"http:\/\/groups.eortc.be\/qol\/eortc-qlq-c30."},{"key":"10.1016\/j.radonc.2018.02.028_b0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0360-3016(93)90289-8","article-title":"Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer","volume":"26","author":"Armstrong","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.02.028_b0110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/cas.12466","article-title":"Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer","volume":"105","author":"Ma","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.radonc.2018.02.028_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2004.06.022","article-title":"Virtual simulation in palliative lung radiation therapy","volume":"16","author":"Driver","year":"2004","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2015.06.017","article-title":"The international Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting","volume":"116","author":"Jeremic","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.02.028_b0125","doi-asserted-by":"crossref","unstructured":"Granton PV, Palma DA, Louie AV. Intentional avoidance of the esophagus using intensity modulated radiation therapy to reduce dysphagia after palliative thoracic radiation. Radiother Oncol 2017;12:27.","DOI":"10.1186\/s13014-017-0771-6"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018301257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018301257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T05:59:15Z","timestamp":1531375155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018301257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0167814018301257"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.02.028","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}